it’s important for pain practitioners to have a strong recognition of [nonopioid] agents’ mechanism of action, pharmacokinetics, and toxicity profiles. This course will provide an in-depth look at...their potential role in pain management, and available data supporting their use.
MONTCLAIR, N.J. (PRWEB) April 01, 2019
PAINWeekEnd on April 27 at the Hilton Austin, 500 E 4th St, in Texas, will be a timely full day program providing busy clinicians and allied healthcare practitioners with 6.0 hours of relevant, practical instruction in the management of chronic pain.
In September 2018, the Texas State Board of Pharmacy began issuing revised prescription forms with enhanced security features that include control numbers which must be reported in the record with every Schedule II prescription, and various printing enhancements designed to validate authenticity and prevent copying. The new forms will become mandatory for prescribers starting June 1 of this year. In addition, prescribers have until September 1 to establish an account on PMP Aware, the state’s prescription drug monitoring program. As regulatory efforts continue to steer patients and practitioners away from opioid therapy for pain, there has been a corresponding increase in interest in other treatment modalities, including nonopioid analgesics.
At PAINWeekEnd Austin, Thomas Gregory, PharmD, BCPS, FASPE, CPE, will present his course Nonopioid Analgesics, Adjuvants, and Antidepressants, about which he commented, “Nonopioid analgesics are often considered firstline therapy for most chronic pain syndromes, and it’s important for pain practitioners to have a strong recognition of these agents’ mechanism of action, pharmacokinetics, and toxicity profiles. This course will provide an in-depth look at each of the agents within these drug classes, their potential role in pain management, and available data supporting their use. I also look forward to sharing some clinically relevant monitoring pearls.” Additionally, Dr. Gregory will be presenting Rational Polypharmacy: An Update for Specific Conditions, a review of multidrug therapy as it applies to the treatment of migraine, neuropathic pain, and musculoskeletal pain conditions.
Other courses to be offered at PAINWeekEnd Austin include Involuntary Tapers: Legal, Ethical, and Clinical Concerns; Embrace Changes and Prevent Overdose: A Basic Blueprint for Legal Risk Mitigation and Response; Cannabis vs Cannabinoids: The Politics of Medical Marijuana; and Get Your Specimens in Order: Timely Use of Test Results. Commercially supported activities—addressing a range of product, disease state, and medical information topics—will also be presented.
For more information about this or other regional conferences, and to register for $129, go to the https://www.painweek.org/conferences/painweekend/austin-tx-2019-conference website. BONUS: PAINWeekEnd registrants may register for the 2019 PAINWeek National Conference, September 3-7, in Las Vegas, for $200 off the regular online published price.
PAINWeekEnd is provided by Global Education Group. About Global Education Group:
Global Education Group focuses on producing partnership-based CME for healthcare practitioners. The Global team works with a select group of medical education companies, associations, academic institutions and healthcare facilities to develop and accredit live healthcare conferences and workshops as well as online activities. With each partnership or joint providership, Global brings accreditation expertise, project management excellence and grant funding intelligence. Based in Littleton, Colo., Global has accreditation with commendation from the ACCME. Global also holds accreditations to offer continuing education for nurses, nurse practitioners, pharmacists, dietitians, dentists and psychologists. Global is a division of Ultimate Medical Academy.